Overview

Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)

Status:
Recruiting

Trial end date:
2022-01-01

Target enrollment:

Participant gender:

Summary

An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy

Phase:

Phase 2

Details

Lead Sponsor:

Blue Earth Diagnostics

Collaborator:

Precision For Medicine